(MediaBuyerPlanner) Various Omnicom Group shops will oversee global advertising for Procter & Gamble’s osteoporosis medication Actonel, Adweek writes. Last year, P&G invested nearly $80 million on advertising Actonel in the U.S., according to Nielsen Monitor-Plus.
DDB in New York will manage consumer marketing efforts for Actonel. The Paris-based unit of DDB, Ciel et Terra, and Chicago-based medical specialist Corbett, will handle professional communications. The shops take over for WPP Group’s Grey in New York, next month.
“We believe Actonel offers important benefits to both consumers and professionals,” said Tom Finn, P&G Pharmaceuticals’ vice president of North American operations and strategic planning. “These agencies collectively offer innovative messaging and marketing capabilities to help us continue to grow the Actonel business and most importantly to help us convince more women at risk of fracture to talk to their doctor about effective treatment options.”
